Estrogen Replacement in Anorexia Nervosa (HOSAN)
Prospective, Randomized, Double-blind, Placebo-controlled Clinical Trial on the Effects of an Estrogen-progestin Combination as add-on to Inpatient Psychotherapy in Adult Female Patients Suffering From Anorexia Nervosa
Sponsor: University of Erlangen-Nürnberg Medical School
Terminated
Difficulties in recruitment
Other terminated trials from University of Erlangen-Nürnberg Medical School
- Head and Neck Squamous Cell Carcinoma · Phase PHASE2 · Oct 2024
- Depression · Phase NA · Dec 2019
- Anaesthesia With Propofol · Apr 2019
- Acute Ischemic Stroke · Phase PHASE3 · Jul 2018
- Intracerebral Hemorrhage · Phase PHASE2 · Apr 2014
See all terminations from University of Erlangen-Nürnberg Medical School
Other Anorexia Nervosa trials with similar outcome
This PHASE2 trial investigates Anorexia Nervosa and is currently terminated or withdrawn. University of Erlangen-Nürnberg Medical School leads this study, which shows 6 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2
-
Feb 2019 — Jan 2021 [monthly]
Terminated PHASE2
Status: Recruiting → Terminated
-
Jun 2018 — Feb 2019 [monthly]
Recruiting PHASE2
▶ Show 1 earlier version
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Mar 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University of Erlangen-Nürnberg Medical School
For direct contact, visit the study record on ClinicalTrials.gov .